Roy S. Herbst, MD, PhD, on Lung Cancer: Update on Immunotherapy

Posted: Sunday, January 28, 2018

Roy S. Herbst, MD, PhD, of the Yale School of Medicine, discusses effective combination therapies and why some tumors are resistant to immunotherapy.